Alnylam Pharmaceuticals, Inc.

Healthcare

NASDAQ:ALNY · NASDAQ Global Select

Market Cap $37.76B Beta 0.27 P/E (TTM) 65.1

$282.85 -2.26%

-$6.54 today

52W Low $281.77High $495.55

Vol 1.40M · Avg 1.11M

EPS (TTM)$4.34

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-8.16%

Period High

$491.22

Period Low

$282.85

Latest

$282.85

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Cigna Corporation

NYSE:CI

$78.83B

Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

$63.06B

argenx SE

NASDAQ:ARGX

$55.29B

Cencora, Inc.

NYSE:COR

$54.80B

Becton, Dickinson and Company

NYSE:BDX

$52.98B

Cardinal Health, Inc.

NYSE:CAH

$52.43B

Edwards Lifesciences Corporation

NYSE:EW

$49.01B

IDEXX Laboratories, Inc.

NASDAQ:IDXX

$44.24B

Zoetis Inc.

NYSE:ZTS

$33.36B

Veeva Systems Inc.

NYSE:VEEV

$25.92B

What is the latest ALNY filing?

The latest filing shown is 4 dated Jun 3, 2026.

How many recent filings does ALNY have?

Intrinsic Alpha currently shows 20 recent filings for ALNY.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.